A large, simple trial of a tuberculosis vaccine

Clinical Infectious Diseases

Volumn 30, Issue SUPPL. 3, 2000, Pages

  Horsburgh C R , Jr ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; PLACEBO;

BCG VACCINATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG SURVEILLANCE PROGRAM; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; BCG VACCINE; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; RANDOMIZED CONTROLLED TRIALS; TUBERCULOSIS, PULMONARY;

EID: 0034465417     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313884     Document Type: Conference Paper

References (10)

1. Field trials of tuberculosis vaccines: How could we have done them better?
2. Tuberculosis vaccines: How close to human testing?
3. Development of new vaccines for tuberculosis recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET)
4. Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic
5. Why do we need some large, simple, randomized trials?
6. Large-scale randomized evidence: Large, simple trials and overviews of trials
7. Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: An international randomized trial
8. Estimation of the annual risk of tuberculosis infection for white men in the United States
9. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus
10. Controlled chemoprophylaxis trials in tuberculosis: A general review